Insulin-regulated hepatic gluconeogenesis through FOXO1–PGC-1α interaction
The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Abstract
Hepatic gluconeogenesis is absolutely required for survival during prolonged fasting or starvation, but is inappropriately activated in diabetes mellitus. Glucocorticoids and glucagon have strong gluconeogenic actions on the liver. In contrast, insulin suppresses hepatic gluconeogenesis. Two components known to have important physiological roles in this process are the forkhead transcription factor FOXO1 (also known as FKHR) and peroxisome proliferative activated receptor-gamma co-activator 1 (PGC-1alpha; also known as PPARGC1), a transcriptional co-activator; whether and how these factors collaborate has not been clear. Using wild-type and mutant alleles of FOXO1, here we show that PGC-1alpha binds and co-activates FOXO1 in a manner inhibited by Akt-mediated phosphorylation. Furthermore, FOXO1 function is required for the robust activation of gluconeogenic gene expression in hepatic cells and in mouse liver by PGC-1alpha. Insulin suppresses gluconeogenesis stimulated by PGC-1alpha but co-expression of a mutant allele of FOXO1 insensitive to insulin completely reverses this suppression in hepatocytes or transgenic mice. We conclude that FOXO1 and PGC-1alpha interact in the execution of a programme of powerful, insulin-regulated gluconeogenesis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“PGC-1α is a key regulator of mitochondrial biogenesis and respiration [27] that plays a critical role in the control of metabolism and energy homeostasis [28-30].”
From PGC-1α in aging and anti-aging interventions (2009) · cites this paper as [30]
In the citing paper
“hepatic gluconeogenesis was suppressed, as witnessed by decreased expression of the FoxO1-regulated genes phosphoenolpyruvate carboxykinase (Pepck) and glucose-6-phosphatase (G6P) [72].”
From Physiologic functions of PP2A: Lessons from genetically modified mice (2019) · cites this paper as [72]
Citations
Cites
Akt Promotes Cell Survival by Phosphorylating and Inhibiting a Forkhead Transcription Factor
Brunet, A., Bonni, A., Zigmond, M. J., Lin, M. Z., Juo, P., Hu, L. S., Anderson, M. J., Arden, K. C., Blenis, J., & Greenberg, M. E. (1999) · Cell · doi:10.1016/s0092-8674(00)80595-4 · Cited by 5,594
A Cold-Inducible Coactivator of Nuclear Receptors Linked to Adaptive Thermogenesis
Puigserver, P., Wu, Z., Park, C. W., Graves, R., Wright, M., & Spiegelman, B. M. (1998) · Cell · doi:10.1016/s0092-8674(00)81410-5 · Cited by 3,864
Self-citationControl of hepatic gluconeogenesis through the transcriptional coactivator PGC-1
Yoon, J. C., Puigserver, P., Chen, G., Donovan, J., Wu, Z., Rhee, J., Adelmant, G., Stafford, J., Kahn, C. R., Granner, D. K., et al. (2001) · Nature · doi:10.1038/35093050 · Cited by 1,821
Self-citationCREB regulates hepatic gluconeogenesis through the coactivator PGC-1
Herzig, S., Long, F., Jhala, U. S., Hedrick, S., Quinn, R., Bauer, A., Rudolph, D., Schutz, G., Yoon, C., Puigserver, P., et al. (2001) · Nature · doi:10.1038/35093131 · Cited by 1,440
Self-citationREGULATION OF PHOSPHOENOLPYRUVATE CARBOXYKINASE (GTP) GENE EXPRESSION
Hanson, R. W., & Reshef, L. (1997) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.66.1.581 · Cited by 729 · cited 1×
“In contrast, insulin suppresses hepatic gluconeogenesi”
The Forkhead Transcription Factor Foxo1 Regulates Adipocyte Differentiation
Nakae, J., Kitamura, T., Kitamura, Y., Biggs, W. H., Arden, K. C., & Accili, D. (2003) · Developmental Cell · doi:10.1016/s1534-5807(02)00401-x · Cited by 727
Self-citationPhosphorylation of the Transcription Factor Forkhead Family Member FKHR by Protein Kinase B
Rena, G., Guo, S., Cichy, S. C., Unterman, T. G., & Cohen, P. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.24.17179 · Cited by 714
Nakae, J., Kitamura, T., Silver, D. L., & Accili, D. (2001) · Journal of Clinical Investigation · doi:10.1172/jci12876 · Cited by 652
Self-citationNakae, J., Kitamura, T., Silver, D. L., & Accili, D. (2001) · Journal of Clinical Investigation · doi:10.1172/jci200112876 · Cited by 652
Self-citationNakae, J., Biggs, W. H., Kitamura, T., Cavenee, W. K., Wright, C. V. E., Arden, K. C., & Accili, D. (2002) · Nature Genetics · doi:10.1038/ng890 · Cited by 616
Self-citation
Cited by
Items 401–500 of 1,000
Forkhead transcription factors and ageing
Partridge, L., & Brüning, J. C. (2008) · Oncogene · doi:10.1038/onc.2008.28 · Cited by 106
“Conversely, insulin-stimulated PGC-1a phosphorylation abrogates its interaction with FOXO1 besides directly phosphorylating FOXO1 (Puigserver et al., 2003).”
BackgroundThe Protein Level of PGC-1α, a Key Metabolic Regulator, Is Controlled by NADH-NQO1
Adamovich, Y., Shlomai, A., Tsvetkov, P., Umansky, K. B., Reuven, N., Estall, J. L., Spiegelman, B. M., & Shaul, Y. (2013) · Molecular and Cellular Biology · doi:10.1128/mcb.01672-12 · Cited by 95
Self-citationChemoprevention of nonalcoholic fatty liver disease by dietary natural compounds
Pan, M., Lai, C., Tsai, M., & Ho, C. (2013) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201300522 · Cited by 99
Yan, F., & Zheng, X. (2017) · Journal of Functional Foods · doi:10.1016/j.jff.2017.01.027 · Cited by 99
Adropin’s Role in Energy Homeostasis and Metabolic Disorders
Ali, I. I., D’Souza, C. M., Singh, J., & Adeghate, E. A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23158318 · Cited by 106
Rare mono- and disaccharides as healthy alternative for traditional sugars and sweeteners?
van Laar, A., Grootaert, C., & Camp, J. V. (2020) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2020.1743966 · Cited by 103
Emerging Therapeutic Potential of SIRT6 Modulators
Fiorentino, F., Mai, A., & Rotili, D. (2021) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.1c00601 · Cited by 98
Clark, J., & Simon, D. K. (2009) · Antioxidants & Redox Signaling · doi:10.1089/ars.2008.2241 · Cited by 93
Kim, J. J., Li, P., Huntley, J., Chang, J. P., Arden, K. C., & Olefsky, J. M. (2009) · Diabetes · doi:10.2337/db08-1001 · Cited by 95
“Although the FoxO1 isoform has been shown to promote the expression of key gluconeogenic enzymes in liver (12,13,21), it is unclear how it contributes to metabolism in other tissues, particularly adipose and skeletal muscle.”
BackgroundFOXO1: A Potential Target for Human Diseases
Lu, H., & Huang, H. (2011) · Current Drug Targets · doi:10.2174/138945011796150280 · Cited by 100
PPARs as Therapeutic Targets: Reverse Cardiology?
Plutzky, J. (2003) · Science · doi:10.1126/science.1091172 · Cited by 96
Erythropoietin, a Novel Versatile Player Regulating Energy Metabolism beyond the Erythroid System
Wang, L., Di, L., & Noguchi, C. T. (2014) · International Journal of Biological Sciences · doi:10.7150/ijbs.9518 · Cited by 96
Functional properties of hepatocytes in vitro are correlated with cell polarity maintenance
Zeigerer, A., Wuttke, A., Marsico, G., Seifert, S., Kalaidzidis, Y., & Zerial, M. (2017) · Experimental Cell Research · doi:10.1016/j.yexcr.2016.11.027 · Cited by 93
Wang, L., Scott, I., Zhu, L., Wu, K., Han, K., Chen, Y., Gucek, M., & Sack, M. N. (2017) · Nature Communications · doi:10.1038/s41467-017-00521-8 · Cited by 91
Targeting SREBPs for treatment of the metabolic syndrome
Soyal, S. M., Nofziger, C., Dossena, S., Paulmichl, M., & Patsch, W. (2015) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2015.04.010 · Cited by 98
Benton, C. R., Wright, D. C., & Bonen, A. (2008) · Applied Physiology, Nutrition, and Metabolism · doi:10.1139/h08-074 · Cited by 91
Fayyaz, S., Henkel, J., Japtok, L., Krämer, S., Damm, G., Seehofer, D., Püschel, G. P., & Kleuser, B. (2013) · Diabetologia · doi:10.1007/s00125-013-3123-6 · Cited by 104
Fukushima, A., Loh, K., Galic, S., Fam, B., Shields, B., Wiede, F., Tremblay, M. L., Watt, M. J., Andrikopoulos, S., & Tiganis, T. (2010) · Diabetes · doi:10.2337/db09-1365 · Cited by 90
Mitochondrial longevity pathways
Vendelbo, M. H., & Nair, K. S. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2011.01.029 · Cited by 93
Thorn, S. R., Brown, L. D., Rozance, P. J., Hay, W. W., & Friedman, J. E. (2013) · Diabetes · doi:10.2337/db11-1727 · Cited by 89
daf-16/FoxO promotes gluconeogenesis and trehalose synthesis during starvation to support survival
Hibshman, J. D., Doan, A. E., Moore, B. T., Kaplan, R. E. W., Hung, A., Webster, A. K., Bhatt, D. P., Chitrakar, R., Hirschey, M. D., & Baugh, L. R. (2017) · eLife · doi:10.7554/elife.30057 · Cited by 95
“Function of trehalose as a stress pro- tectant during starvation provides some resolution to this paradox, but upregulation of gluconeo- genesis during starvation also occurs in mammals (Puigserver et al., 2003), though they do not produce trehalose.”
BackgroundShao, J., Qiao, L., Janssen, R. C., Pagliassotti, M., & Friedman, J. E. (2005) · Diabetes · doi:10.2337/diabetes.54.4.976 · Cited by 90
Irimia, J. M., Meyer, C. M., Peper, C. L., Zhai, L., Bock, C. B., Previs, S. F., McGuinness, O. P., DePaoli-Roach, A., & Roach, P. J. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.106534 · Cited by 88
The Fox Genes in the Liver: From Organogenesis to Functional Integration
Lay, J. E. L., & Kaestner, K. H. (2010) · Physiological Reviews · doi:10.1152/physrev.00018.2009 · Cited by 104
Estrogen-related Receptor α Is a Repressor of Phosphoenolpyruvate Carboxykinase Gene Transcription
Herzog, B., Cardenas, J., Hall, R. K., Villena, J. A., Budge, P. J., Giguère, V., Granner, D. K., & Kralli, A. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m509276200 · Cited by 87
Mitochondrial dynamics in cancer-induced cachexia
van der Ende, M., Grefte, S., Plas, R., Meijerink, J., Witkamp, R. F., Keijer, J., & van Norren, K. (2018) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2018.07.008 · Cited by 87
Nuclear receptors as therapeutic targets in liver disease: are we there yet?
Rudraiah, S., Zhang, X., & Wang, L. (2016) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010715-103209 · Cited by 87
“FOXO1 is directly and indirectly activated by PGC1α, HNF4α, ChREBP, and PPARα, and furthermore, PGC1α-FOXO1 complex is considered a potential target for antigluconeogenic therapies for diabetes mellitus (12, 22).”
Lu, G., Liu, Z., Wang, X., & Wang, C. (2021) · Foods · doi:10.3390/foods10051030 · Cited by 99
Futile cycles: Emerging utility from apparent futility
Sharma, A. K., Khandelwal, R., & Wolfrum, C. (2024) · Cell Metabolism · doi:10.1016/j.cmet.2024.03.008 · Cited by 94
Partnership of PGC-1α and HNF4α in the Regulation of Lipoprotein Metabolism
Rhee, J., Ge, H., Yang, W., Fan, M., Handschin, C., Cooper, M., Lin, J., Li, C., & Spiegelman, B. M. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m512636200 · Cited by 86
Self-citationFoxo Factors: A Matter of Life and Death
Huang, H., & Tindall, D. J. (2006) · Future Oncology · doi:10.2217/14796694.2.1.83 · Cited by 92
“FOXO1 also regulates cell survival in hepatic cells by interacting with the transcription coactivator peroxisome proliferator-activated receptor-γ coactivator (PGC)-1, thereby modulating gluconeogenesis [29].”
BackgroundBiological and catalytic functions of sirtuin 6 as targets for small-molecule modulators
Klein, M. A., & Denu, J. M. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.rev120.011438 · Cited by 88
Foxo1 links insulin signaling to C/EBPα and regulates gluconeogenesis during liver development
Sekine, K., Chern, E., Kojima, N., Ogata, K., Fukamizu, A., & Miyajima, A. (2007) · The EMBO Journal · doi:10.1038/sj.emboj.7601784 · Cited by 96
“Foxo1 is a member of the forkhead family transcription factors and regulates glucose metabolism in the adult liver (Puigserver et al, 2003; Accili and Arden, 2004).”
BackgroundMetformin induces PGC‐1α expression and selectively affects hepatic PGC‐1α functions
Aatsinki, S., Buler, M., Salomäki, H., Koulu, M., Pavek, P., & Hakkola, J. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12585 · Cited by 85
“KLF15, FOXO1 and HNF-4α are the transcription factors that activate the gluconeogenic genes together with PGC-1α (Puigserver et al., 2003; Rhee et al., 2003; Takashima et al., 2010).”
BackgroundSystem-based approaches to decode the molecular links in Parkinson's disease and diabetes
Santiago, J. A., & Potashkin, J. A. (2014) · Neurobiology of Disease · doi:10.1016/j.nbd.2014.03.019 · Cited by 95
Role of miRNAs in development and disease: Lessons learnt from small organisms
Chandra, S., Vimal, D., Sharma, D., Rai, V., Gupta, S. C., & Chowdhuri, D. K. (2017) · Life Sciences · doi:10.1016/j.lfs.2017.07.017 · Cited by 95
Kim, D. H., Park, M. H., Ha, S., Bang, E. J., Lee, Y., Lee, A. K., Lee, J., Yu, B. P., & Chung, H. Y. (2019) · Aging · doi:10.18632/aging.101838 · Cited by 88
“PGC1α interacts with FoxO1 and coactivates FoxO1dependent gene expression [35].”
BackgroundBioactive compounds from Polygonatum genus as anti-diabetic agents with future perspectives
Shi, Y., Si, D., Chen, D., Zhang, X., Han, Z., Yu, Q., Liu, J., & Si, J. (2022) · Food Chemistry · doi:10.1016/j.foodchem.2022.135183 · Cited by 87
Oxidative Stress, Intrauterine Growth Restriction, and Developmental Programming of Type 2 Diabetes
Rashid, C. S., Bansal, A., & Simmons, R. A. (2018) · Physiology · doi:10.1152/physiol.00023.2018 · Cited by 91
Ablation of ARNT/HIF1β in Liver Alters Gluconeogenesis, Lipogenic Gene Expression, and Serum Ketones
Wang, X. L., Suzuki, R., Lee, K., Tran, T., Gunton, J. E., Saha, A. K., Patti, M.-E., Goldfine, A., Ruderman, N. B., Gonzalez, F. J., et al. (2009) · Cell Metabolism · doi:10.1016/j.cmet.2009.04.001 · Cited by 83
“Thus, three transcription factors (FXR, SREBP-1c, and C/EBPα) involved in the regulation of hepatic lipogenesis (Pedersen et al., 2007; Qiao et al., 2006; Sinal et al., 2000; Foufelle and Ferre, 2002; Horton et al., 2002; Puigserver et al., 2003) are increased in the L-ARNT KO mice and could contribute to the increase…”
BackgroundcAMP-dependent Signaling Regulates the Adipogenic Effect of n-6 Polyunsaturated Fatty Acids
Madsen, L., Pedersen, L. M., Liaset, B., Ma, T., Petersen, R. K., van den Berg, S. A. A., Pan, J., Müller‐Decker, K., Dülsner, E., Kleemann, R., et al. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m707775200 · Cited by 97
Chang, J. S., Huypens, P., Zhang, Y., Black, C., Kralli, A., & Gettys, T. W. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.083121 · Cited by 84
Lynch, M. R., Tran, M. T., & Parikh, S. M. (2018) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00263.2017 · Cited by 85
Insulin Regulation of Cholesterol 7α-Hydroxylase Expression in Human Hepatocytes
Li, T., Kong, X., Owsley, E., Ellis, E. C. S., Strom, S. C., & Chiang, J. Y. L. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m605815200 · Cited by 87
Immune and Neuroprotective Effects of Physical Activity on the Brain in Depression
Phillips, C., & Fahimi, A. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00498 · Cited by 81
“…receptor (PPAR)γ (Puigserver and Spiegelman, 2003), PPARα (Vega et al., 2000), estrogen-related α (ERRα) (Huss et al., 2002), forkhead box O (FoxO) (Puigserver et al., 2003), hepatocyte nuclear factor 4α (HNF4α) (Yoon et al., 2001), and nuclear respiratory factors (NRFs) (Wu et al., 1999).”
BackgroundPGC-1s in the Spotlight with Parkinson’s Disease
Piccinin, E., Sardanelli, A. M., Seibel, P., Moschetta, A., Cocco, T., & Villani, G. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22073487 · Cited by 87
The effects of aging and oxidative stress on learning behavior in C. elegans
Murakami, S., & Murakami, H. (2004) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2004.08.007 · Cited by 88
Oh, K.-J., Park, J., Kim, S. S., Oh, H., Choi, C. S., & Koo, S.-H. (2012) · PLoS Genetics · doi:10.1371/journal.pgen.1002986 · Cited by 83
Xiong, S., Salazar, G., San Martin, A., Ahmad, M., Patrushev, N., Hilenski, L., Nazarewicz, R. R., Ma, M., Ushio-Fukai, M., & Alexander, R. W. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.065235 · Cited by 85
Kim, J.-Y., Kim, H.-J., Kim, K. T., Park, Y.-Y., Seong, H.-A., Park, K. C., Lee, I.-K., Ha, H., Shong, M., Park, S. C., et al. (2004) · Molecular Endocrinology · doi:10.1210/me.2004-0211 · Cited by 83
Chowdhury, S. K. R., Dobrowsky, R. T., & Fernyhough, P. (2011) · Mitochondrion · doi:10.1016/j.mito.2011.06.007 · Cited by 82
“…factors impacting on whole-body energy expenditure, including myocyte enhancer factor-2, forkhead O-box (FOXO) transcription factors and nuclear receptors (e.g. PPARs and estrogen-related receptors) (Feige and Auwerx, 2007; Michael et al., 2001; Puigserver et al., 2003; Vega et al., 2000).”
Multiple Levels of PGC-1α Dysregulation in Heart Failure
Oka, S., Sabry, A. D., Cawley, K. M., & Warren, J. S. (2020) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2020.00002 · Cited by 92
Miceli, C., Roccio, F., Penalva-Mousset, L., Burtin, M., Leroy, C., Nemazanyy, I., Kuperwasser, N., Pontoglio, M., Friedlander, G., Morel, É., et al. (2020) · Nature Cell Biology · doi:10.1038/s41556-020-0566-0 · Cited by 92
Sun, Z., Shao, Y., Yan, K., Yao, T., Liu, L., Sun, F., Wu, J., & Huang, Y. (2023) · Metabolites · doi:10.3390/metabo13101048 · Cited by 100
“Consequently, zinc possesses the capacity to attenuate gluconeogenesis activity in mice [47].”
BackgroundDissecting the role of insulin resistance in the metabolic syndrome
Haas, J. T., & Biddinger, S. B. (2009) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e32832b2024 · Cited by 80
Takayama, H., Misu, H., Iwama, H., Chikamoto, K., Saito, Y., Murao, K., Teraguchi, A., Lan, F., Kikuchi, A., Saito, R., et al. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.479386 · Cited by 91
“The ability of FoxO1 to increase the expression of gluconeogenic genes has been confirmed (35).”
BackgroundWhole body overexpression of PGC-1α has opposite effects on hepatic and muscle insulin sensitivity
Liang, H., Balas, B., Tantiwong, P., Dube, J., Goodpaster, B. H., O'Doherty, R. M., DeFronzo, R. A., Richardson, A., Musi, N., & Ward, W. F. (2009) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.90292.2008 · Cited by 81
Williams, K. J., & Wu, X. (2016) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2016.02.004 · Cited by 87
“After a meal, there is no need for the liver to cannibalize amino acids to make new molecules of glucose, and so AKT-mediated phosphorylation of FOXO1 also shuts off gluconeogenic genes, such as phosphoenolpyruvate carboxykinase 1 (Pepck) (Figure 3A and references [277, 305, 306]).”
BackgroundEpigenetic modification and therapeutic targets of diabetes mellitus
Singh, R., Chandel, S., Dey, D., Ghosh, A., Roy, S., Ravichandiran, V., & Ghosh, D. (2020) · Bioscience Reports · doi:10.1042/bsr20202160 · Cited by 88
Wang, J., Fröhlich, H., Torres, F. B., Silva, R. L., Poschet, G., Agarwal, A., & Rappold, G. A. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2112852119 · Cited by 81
“An example is Pgc-1α [35, 47], regulated by Foxo1, which is a transcriptional coactivator and master regulator of mitochondrial biogenesis.”
BackgroundChoi, D., Oh, K.-J., Han, H.-S., Yoon, Y.-S., Jung, C.-Y., Kim, S.-T., & Koo, S.-H. (2012) · Hepatology · doi:10.1002/hep.25809 · Cited by 81
Yamamoto, J., Ikeda, Y., Iguchi, H., Fujino, T., Tanaka, T., Asaba, H., Iwasaki, S., Ioka, R. X., Kaneko, I. W., Magoori, K., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m312079200 · Cited by 90
Li, Q., Zhao, Q., Zhang, J., Zhou, L., Zhang, W., Chua, B. T., Chen, Y., Xu, L. M., & Li, P. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.08.066 · Cited by 85
GCN5 acetyltransferase in cellular energetic and metabolic processes
Mutlu, B., & Puigserver, P. (2020) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2020.194626 · Cited by 88
“Aberrations in glucose homeostasis can result in deleterious clinical outcomes, such as in Type 2 Diabetes Mellitus (T2DM).”
BackgroundSelf-citationWu, C., Khan, S. A., Peng, L.-J., & Lange, A. J. (2006) · Advances in Enzyme Regulation · doi:10.1016/j.advenzreg.2006.01.010 · Cited by 91
Xiong, S., Salazar, G., Patrushev, N., Ma, M., Forouzandeh, F., Hilenski, L., & Alexander, R. W. (2013) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.112.301019 · Cited by 79
Yan, F., Zhang, J., Zhang, L., & Zheng, X. (2016) · Food & Function · doi:10.1039/c5fo00841g · Cited by 86
Metabolic roles of PGC-1α and its implications for type 2 diabetes
Besseiche, A., Riveline, J., Gautier, J., Bréant, B., & Blondeau, B. (2015) · Diabetes & Metabolism · doi:10.1016/j.diabet.2015.02.002 · Cited by 97
“[34] Puigserver P, Rhee J, Donovan J, Walkey CJ, Yoon JC, Oriente F, et al.”
BackgroundNuclear Mechanisms of Insulin Resistance
Kang, S., Tsai, L. T.-Y., & Rosen, E. D. (2016) · Trends in Cell Biology · doi:10.1016/j.tcb.2016.01.002 · Cited by 88
“The induction of gluconeogenesis by PGC-1/ is mediated via direct interaction with FOXO1; Aktmediated phosphorylation and expulsion of FOXO1 from the nucleus disrupts the FOXO1–PGC1/ interaction, thereby suppressing gluconeogenesis [84].”
BackgroundDual Regulation of Gluconeogenesis by Insulin and Glucose in the Proximal Tubules of the Kidney
Sasaki, M., Sasako, T., Kubota, N., Sakurai, Y., Takamoto, I., Kubota, T., Inagi, R., Seki, G., Goto, M., Ueki, K., et al. (2017) · Diabetes · doi:10.2337/db16-1602 · Cited by 79
Arukwe, A. (2005) · Environmental Science & Technology · doi:10.1021/es0509937 · Cited by 86
FOXO1 orchestrates the bone-suppressing function of gut-derived serotonin
Kode, A., Mosialou, I., Silva, B. C., Rached, M.-T., Zhou, B., Wang, J., Townes, T. M., Hen, R., DePinho, R. A., Guo, X. E., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci64906 · Cited by 80
Yoon, Y.-S., Lee, M., Ryu, D., Kim, J. H., Ma, H., Seo, W., Kim, Y.-N., Kim, S. S., Lee, C. H., Hunter, T. R., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1012665107 · Cited by 80
Transcriptional Regulation of Hepatic Fatty Acid Metabolism
Guillou, H., Martin, P. G. P., & Pineau, T. (2008) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-1-4020-8831-5_1 · Cited by 90
“FoxO also interacts with PGC1-a (Puigserver et al., 2003) and regulates the expression of target genes that include several key enzymes of neoglucogenesis (Barthel et al.”
BackgroundFOXO regulates RNA interference in Drosophila and protects from RNA virus infection
Spellberg, M. J., & Marr, M. T. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1517124112 · Cited by 87
Chronic Uridine Administration Induces Fatty Liver and Pre-Diabetic Conditions in Mice
Urasaki, Y., Pizzorno, G., & Le, T. T. (2016) · PLoS ONE · doi:10.1371/journal.pone.0146994 · Cited by 83
FoxO1: A molecule for all seasons
Kousteni, S. (2010) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.306 · Cited by 86
Distinct C/EBPα motifs regulate lipogenic and gluconeogenic gene expression in vivo
Pedersen, T. Å., Bereshchenko, O., García-Silva, S., Ermakova, O. V., Kurz, E., Mandrup, S., Porse, B. T., & Nerlov, C. (2007) · The EMBO Journal · doi:10.1038/sj.emboj.7601563 · Cited by 88
“PGC-1a expression is induced in the liver via the cAMP–CREB axis (Herzig et al, 2001), and regulates gluco- neogenic gene expression by acting as a co–factor for Foxo1, an interaction disrupted by insulin-mediated Foxo1 phos- phorylation (Puigserver et al, 2003).”
BackgroundKuo, M.-S., Zilberfarb, V., Gangneux, N., Christeff, N., & Issad, T. (2008) · Biochimie · doi:10.1016/j.biochi.2008.03.005 · Cited by 84
Post-translational modification of pregnane x receptor
Staudinger, J. L., Xu, C., Biswas, A., & Mani, S. (2011) · Pharmacological Research · doi:10.1016/j.phrs.2011.02.011 · Cited by 83
Yang, J., Kong, X., Martins-Santos, M. E. S., Aleman, G., Chaco, E., Liu, G. E., Wu, S.-Y., Samols, D., Hakimi, P., Chiang, C.-M., et al. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.047340 · Cited by 78
Gali Ramamoorthy, T., Laverny, G., Schlagowski, A.-I., Zoll, J., Messaddeq, N., Bornert, J.-M., Panza, S., Ferry, A., Geny, B., & Metzger, D. (2015) · Nature Communications · doi:10.1038/ncomms10210 · Cited by 74
PGC-1α in Disease: Recent Renal Insights into a Versatile Metabolic Regulator
Chambers, J. M., & Wingert, R. A. (2020) · Cells · doi:10.3390/cells9102234 · Cited by 82
Deng, X., Dong, Q., Bridges, D., Raghow, R., Park, E. A., & Elam, M. B. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2015.08.007 · Cited by 81
Transcriptional regulators of hepatic gluconeogenesis
Oh, K., Han, H.-S., Kim, M.-J., & Koo, S. (2013) · Archives of Pharmacal Research · doi:10.1007/s12272-013-0018-5 · Cited by 85
FoxO1 Protein Cooperates with ATF4 Protein in Osteoblasts to Control Glucose Homeostasis
Kode, A., Mosialou, I., Silva, B. C., Joshi, S., Ferron, M., Rached, M. T., & Kousteni, S. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.282897 · Cited by 77
Manmontri, B., Sarıahmetoğlu, M., Donkor, J., Khalil, M. B., Sundaram, M., Yao, Z., Reue, K., Lehner, R. S., & Brindley, D. N. (2008) · Journal of Lipid Research · doi:10.1194/jlr.m800013-jlr200 · Cited by 83
Moreno, M., Lombardi, A., Silvestri, E., Senese, R., Cioffi, F., Goglia, F., Lanni, A., & de Lange, P. (2010) · PPAR Research · doi:10.1155/2010/435689 · Cited by 87
“PGC-1 family members can interact not only with PPARs but also with other members of the nuclear receptor superfamily, such as ERR, LXR, and HNF-4α [62–64], and with distinct transcription factors and regulatory elements, including cAMP response element-binding protein (CREB), the lipogenic transcription factor sterol…”
BackgroundHall, R. K., Wang, X. L., George, L., Koch, S. R., & Granner, D. K. (2007) · Molecular Endocrinology · doi:10.1210/me.2006-0307 · Cited by 75
Phenobarbital Confers its Diverse Effects by Activating the Orphan Nuclear Receptor Car
Kodama, S., & Negishi, M. (2006) · Drug Metabolism Reviews · doi:10.1080/03602530600569851 · Cited by 76
“…directly bind to a consensus sequence [(T/C)(G/A)AAACAA] known as the insulin response sequence (IRS) in the promoter region of gluconeogenic genes, such as PEPCK1 and G6Pase, and activate their transcription (Schmoll et al., 2000; Yeagley et al., 2001; Nakae et al., 2001; Puigserver et al., 2003).”
BackgroundEffects of Ginsenoside Rg3 on fatigue resistance and SIRT1 in aged rats
Yang, Q., Lai, X., Ouyang, J., & Yang, J. (2018) · Toxicology · doi:10.1016/j.tox.2018.08.010 · Cited by 78
Southgate, R. J., Bruce, C. R., Carey, A. L., Steinberg, G. R., Walder, K., Monks, R., Watt, M. J., Hawley, J. A., Birnbaum, M. J., & Febbraio, M. A. (2005) · The FASEB Journal · doi:10.1096/fj.05-3993fje · Cited by 74
“Apart from MEF2 and CREB binding sites on the PGC-1a promoter, there also exists a trio of insulin responsive elements that are activated by the forkhead box class-O (FoxO1) winged helix transcription factor (15, 18 ).”
BackgroundRetractedWeighing In on mTOR Complex 2 Signaling: The Expanding Role in Cell Metabolism
Luo, Y., Xu, W., Li, G., & Cui, W. (2018) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2018/7838647 · Cited by 75
“The effect of mTORC2 on gluconeogenesis mainly results from the upregulation of several key gluconeogenic enzymes, such as G6Pase and PEPCK, through Akt-mediated FoxO1-phosphorylation, which leads to nuclear exclusion of FoxO1 and reduction of its transcriptional activities [67, 68].”
BackgroundDeregulated transcription factors in cancer cell metabolisms and reprogramming
Kant, R., Manne, R., Anas, M., Penugurti, V., Chen, T., Pan, B., Hsu, C.-C., & Lin, H. (2022) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2022.10.001 · Cited by 81
Xu, E., Schwab, M. G., & Marette, A. (2013) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-013-9282-4 · Cited by 86
Apolipoprotein A-IV Reduces Hepatic Gluconeogenesis through Nuclear Receptor NR1D1
Li, X., Xu, M., Wang, F., Kohan, A. B., Haas, M. K., Yang, Q., Lou, D., Obici, S., Davidson, W. S., & Tso, P. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.511766 · Cited by 84
“We observed that apoA-IV acts to lower blood glucose and suppress PEPCK and Glc-6-Pase gene expression in the absence of its effect on insulin secretion and in isolated hepatocytes in vitro.”
BackgroundInfluentialIdentification of the tyrosine phosphatase PTP-MEG2 as an antagonist of hepatic insulin signaling
Cho, C. Y., Koo, S., Wang, Y., Callaway, S., Hedrick, S. A., Mak, P. A., Orth, A. P., Peters, E. C., Sáez, E., Montminy, M., et al. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.03.006 · Cited by 77
“In the absence of insulin stimulation, FOXO1 is localized to the nucleus and acts in concert with the peroxisome proliferator-activated receptor-g coactivator 1 a (PGC-1a) to increase gluconeogenic gene transcription (Puigserver et al., 2003).”
Fang, P., Sun, Y., Gu, X., Shi, M., Bo, P., Zhang, Z., & Bu, L. (2019) · Phytomedicine · doi:10.1016/j.phymed.2019.153074 · Cited by 74
Alolga, R. N., Nuer-Allornuvor, G. F., Kuugbee, E. D., Yin, X., & Ma, G. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.104630 · Cited by 76
FKBP51 and the molecular chaperoning of metabolism
Smedlund, K., Sánchez, E. R., & Hinds, T. D. (2021) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2021.08.003 · Cited by 81
Metadata
- Authors
- Puigserver, P., Rhee, J., Donovan, J., Walkey, C. J., Yoon, J. C., Oriente, F., Kitamura, Y., Altomonte, J., Dong, H., Accili, D., & Spiegelman, B. M.
- Affiliations
- Harvard University (US)
- Columbia University (US)
- Icahn School of Medicine at Mount Sinai (US)
- Corresponding author
- Spiegelman, Bruce M.
- ORCID
- Venue
- Nature
- Published
- 2003-05-18
- Volume
- 423
- Issue
- 6939
- Pages
- 550-555
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1583767403
- Cited by
- 1,487
- References
- 22
- Citations by year
- 2026: 31 · 2025: 45 · 2024: 46 · 2023: 53 · 2022: 62 · 2021: 67 · 2020: 71 · 2019: 61 · 2018: 86 · 2017: 76 · 2016: 59 · 2015: 75 · 2014: 71 · 2013: 68 · 2012: 81
- FWCI
- 21.04
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springernature.com/gp/researchers/text-and-data-mining (tdm)
- www.springernature.com/gp/researchers/text-and-data-mining (vor)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- Taiho Pharmaceutical
- National Institutes of Health
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › FOXO transcription factor regulation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fibroblast Growth Factor Research
- Keywords
- hepatic gluconeogenesis, insulin signaling, FOXO1, PGC-1α, transcriptional coactivation, Akt phosphorylation, fasting, diabetes mellitus, glucocorticoids, glucagon, gluconeogenic gene expression, hepatocytes, forkhead transcription factor
- MeSH terms
- Forkhead Box Protein O1, Animals, Cells, Cultured, DNA-Binding Proteins, Gene Expression Regulation, Gluconeogenesis, Insulin, Liver, Precipitin Tests, Protein Binding, RNA, Messenger, Transcription Factors, Hepatocytes, Mice, Forkhead Transcription Factors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.